Showing results (611-620 of 669) with videos related to

Sort By:
Pageof 67
Molecular Cancer Therapeutics|August 13, 2009
A novel hTERT promoter-driven E1A therapeutic for ovarian cancerXiaoming Xie, Jennifer L Hsu, Min-Gew Choi, et al.
Clinical & Experimental Metastasis|April 9, 2014
FN14 expression correlates with MET in NSCLC and promotes MET-driven cell invasionTimothy G Whitsett, Shannon P Fortin Ensign, Harshil D Dhruv, et al.
Molecular Psychiatry|February 7, 2024
Precision medicine for psychotic disorders: objective assessment, risk prediction, and pharmacogenomicsM D Hill, S S Gill, H Le-Niculescu, et al.
The Journal of Heart Transplantation|January 1, 1989
Efficacy and safety of constant-rate intravenous cyclosporine infusion immediately after heart transplantationT J Schroeder, S A Myre, D B Melvin, et al.
Infection and Immunity|November 22, 2005
Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteersNadav Orr, David E Katz, Jacob Atsmon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 16, 2009
PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomasCelestine S Tung, Samuel C Mok, Yvonne T M Tsang, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 14, 2017
miR-122 Release in Exosomes Precedes Overt Tolvaptan-Induced Necrosis in a Primary Human Hepatocyte Micropatterned Coculture ModelMerrie Mosedale, J Scott Eaddy, O Joseph Trask, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 2020
Electronic Dose Monitoring Identifies a High-Risk Subpopulation in the Treatment of Drug-resistant Tuberculosis and Human Immunodeficiency VirusJennifer R Zelnick, Amrita Daftary, Christina Hwang, et al.
Pageof 67